Curriculum Vitae

ASSOCIATE PROF. DR. SUHAILAH BINTI ABDULLAH

Associate Professor
  • Department of Medicine
    Faculty of Medicine
  • +603-79492299

AREAS OF EXPERTISE

  • CENTRAL NERVOUS SYSTEM
    Auto immune Encephalitis (Anti NMDAR encephalitis)
  • CENTRAL NERVOUS SYSTEM
    Idiopathic Inflammatory Demyelinating Diseases (Multiple Sclelosis and spectrum disease)
  • CENTRAL NERVOUS SYSTEM
    General Neurology

ACADEMIC QUALIFICATION

  • CCT (Neurology), (Neurology)
    Ministry of Health Training Board of Neurology,Malaysia
  • MIntMed, (Internal Medicine)
    Universiti Malaya (UM)
  • MBBS (Hons), (Perubatan dan Pembedahan)
    University of Tasmania, Australia
  • BMedSc (Hons), (Medical Science)
    University of Tasmania, Australia

ADMINISTRATIVE DUTIES

  • Coordinator
    01 Jul 2022 - 30 Jun 2024 (Department of Medicine, Faculty of Medicine)
  • Coordinator
    01 Jul 2022 - 30 Jun 2024 (Department of Medicine, Faculty of Medicine)
  • Coordinator
    01 Jul 2022 - 30 Jun 2024 (Department of Medicine, Faculty of Medicine)
  • Coordinator
    10 Dec 2020 - 31 Dec 2022 (University Malaya)
  • Chairman
    03 Jun 2016 - 31 Dec 2022 (Department of Medicine, Faculty of Medicine)
  • Coordinator
    01 Jul 2020 - 30 Jun 2022 (University Malaya)
  • Coordinator
    01 Apr 2019 - 31 Dec 2021 (Department of Medicine, Faculty of Medicine)
  • Coordinator
    29 Jan 2021 - 31 Dec 2021 (Department of Medicine, Faculty of Medicine)
  • Chairman
    03 Jun 2016 - 31 Dec 2021 (Department of Medicine, Faculty of Medicine)
  • Organizing Committee Neuroinfection Workshop
    01 Aug 2019 - 30 Nov 2019 (National)
  • Examiner for MMed Part 1
    26 Nov 2019 - 26 Nov 2019 (University Malaya)
  • Organizing and Scientific Commmittee Neuimmunology Workshop
    01 Aug 2019 - 20 Oct 2019 (National)
  • Examiner EOP 3.2
    18 Sep 2019 - 18 Sep 2019 (University Malaya)
  • Examiner Supplementary Barrier Exam 3.2
    12 Jun 2019 - 12 Jun 2019 (University Malaya)
  • Examiner MMed Part 2
    30 Apr 2019 - 30 Apr 2019 (University Malaya)
  • Examiner EOP 3.1
    13 Mar 2019 - 13 Mar 2019 (University Malaya)
  • Examiner Mock Remedial Barrier exam 3.2
    23 Jan 2019 - 23 Jan 2019 (University Malaya)
  • Examiner UMMPY2 Barrier Exam
    09 Jan 2019 - 09 Jan 2019 (University Malaya)
  • Coordinator for Neurology UMMP 3.1 and 3.2 OBA and EMQ
    01 Jan 2018 - 31 Dec 2018 (University Malaya)
  • Chairperson for CHAMPION (5U/ 9SB)
    01 Jan 2018 - 31 Dec 2018 (University Malaya)
  • Coordinator for Neurology Day Care Unit
    01 Jan 2018 - 31 Dec 2018 (University Malaya)
  • Scientific Committee for Third Regional SEA Therapeutic Plasma Exchange conference, KL
    14 Dec 2018 - 15 Dec 2018 (International)
  • Organizing and Scientific committee for Updates in Demyelinating diseases of the CNS, Penang
    17 Nov 2018 - 17 Nov 2018 (National)
  • Organizing committee Updates on CNS Infection, HKL
    11 Aug 2018 - 11 Aug 2018 (National)
  • Organizing committee MS Summit 2018, University Malaya
    04 Aug 2018 - 04 Aug 2018 (National)
  • Examiner EOP 3.1
    04 Jul 2018 - 04 Jul 2018 (University Malaya)
  • Examiner Master in Psychiatry Clinical Examination Part 2
    15 May 2018 - 15 May 2018 (University Malaya)
  • Examiner MMed mock Clinical examination: Revision Course Part 1
    17 Apr 2018 - 17 Apr 2018 (University Malaya)
  • Examiner Barrier Assessment 3.2
    10 Apr 2018 - 10 Apr 2018 (University Malaya)
  • Examiner EOP 3.2
    21 Mar 2018 - 21 Mar 2018 (National)
  • Examiner MMed Part 2 (Written)
    20 Sep 2017 - 20 Sep 2017 (University Malaya)
  • Examiner EOP 3.1
    23 Aug 2017 - 23 Aug 2017 (University Malaya)
  • Revision Course MMed Part 2
    07 Aug 2017 - 07 Aug 2017 (University Malaya)
  • Committee member of Root Cause Analysis
    01 Feb 2016 - 31 Jul 2017 (University Malaya)
  • Chairperson of CHAMPIONS committee for infection control
    01 Jul 2016 - 30 Jun 2017 (University Malaya)
  • Examiner MMed Part 2 (Written)
    29 Mar 2017 - 29 Mar 2017 (University Malaya)
  • Examiner EOP 3.2
    15 Mar 2017 - 15 Mar 2017 (University Malaya)
  • Revision Course MMed Part 2
    20 Feb 2017 - 20 Feb 2017 (University Malaya)
  • Examiner OSCE stage 2 MBBS
    10 Jan 2017 - 10 Jan 2017 (University Malaya)
  • Supervisor for MBBS 3B Medical CPC: Neurocyticercosis
    06 Jan 2017 - 06 Jan 2017 (University Malaya)
  • Examiner EOP 3B MBBS
    16 Nov 2016 - 16 Nov 2016 (University Malaya)
  • Examiner EOP 3.1 MBBS
    12 Oct 2016 - 12 Oct 2016 (University Malaya)
  • Examiner MMed part 1, Theory
    06 Oct 2016 - 06 Oct 2016 (National)
  • Coordinator UMMPY2 Neurology Block
    24 Jun 2015 - 30 Jun 2016 (University Malaya)
  • Examiner Master of Internal Medicine short cases, Part I
    19 May 2016 - 19 May 2016 (National)
  • Examiner MBBS, Short Cases Year 2
    06 Jan 2016 - 06 Jan 2016 (University Malaya)
  • Clinical Expert, PBL Neuroscience UMMPY2, Multiple Sclerosis, 2014-2015
    14 Aug 2014 - 14 Dec 2015 (University Malaya)
  • Examiner for OSCE stage II (MBBS-UMMP)
    29 Apr 2015 - 29 Jun 2015 (University Malaya)
  • Examiner for Master of Psychiatry -clinical part II
    21 May 2015 - 21 May 2015 (University Malaya)
  • Examiner Final MBBS short case session 2013/ 2015
    09 Apr 2015 - 09 Apr 2015 (University Malaya)
  • Clinical case coordinator (Neurology), MBBS Phase IIIA
    15 Sep 2014 - 09 Oct 2014 (University Malaya)
  • Pemeriksa Kertas OSCE, MBBS phase III session 2013/ 2014
    24 Sep 2014 - 24 Sep 2014 (University Malaya)
  • Examiner, Community Families Case Studies, MBBS phase IIIA session 2011/ 2012
    09 Jul 2014 - 09 Jul 2014 (University Malaya)
  • Pemeriksa Kertas Jawapan Kertas II- CPC PeperiksaanAkhir MBBS Sesi 2012/2014
    18 Mar 2014 - 21 Mar 2014 (University Malaya)
  • Clinical case coordinator for MMed part II session 2013/ 2014
    04 Mar 2013 - 23 May 2013 (University Malaya)
  • Pemeriksa Pra-Klinikal, Master of Internal Medicine, November 2012
    12 Nov 2012 - 12 Nov 2012 (University Malaya)
  • Pengawas Peperiksaan,Master of Internal Medicine Part II, October 2012
    04 Oct 2012 - 05 Oct 2012 (University Malaya)
  • Pengawas Peperiksaan Clinical, Master of Internal Medicine Part I, May 2012
    14 May 2012 - 14 May 2012 (University Malaya)
  • Pengawas Peperiksaan, Master of Internal Medicine Part I, April 2012
    09 Apr 2012 - 10 Apr 2012 (University Malaya)
  • Tutor, PBL MBBS phase IIIA Session 2011/ 2012, Class 2009/ 2014
    26 Mar 2012 - 26 Mar 2012 (University Malaya)
  • Clinical coordinator, Master of Internal medicine Part I, session 2008/ 2009
    13 Apr 2009 - 22 May 2009 (University Malaya)

MEMBERSHIPS

  • AHLI BERSEKUTU MAJLIS PROFESSOR NEGARA, MEMBER
    Since 2022 (National)
  • NATIONAL SPECIALIST REGISTRY INTENAL MEDICINE, MEMBER
    Since 2013 (National)
  • ORDINARY MEMBER, MEMBER
    Since 2013 (National)
  • NATIONAL SPECIALIST REGISTRY NEUROLOGY, MEMBER
    Since 2013 (National)
  • MALAYSIAN SOCIETY OF NEUROSCIENCES, MEMBER
    2022 to 2022 (National)
  • NEUROIMMUNOLOGY AND NEUROINFECTION CHAPTER, VICE PRESIDENT
    2022 to 2022 (National)
  • COMMITTEE MEMBER, MEMBER
    2018 to 2022 (International)
  • ORDINARY MEMBER, MEMBER
    2021 to 2021 (National)
  • MASTER OF INTERNAL MEDICINE PART 1, EXAMINER
    2019 to 2019 (University)
  • UPDATES IN DEMYELINATING DISEASES OF THE CNS, ORGANISING COMMITTEE
    2019 to 2019 (National)

AWARD AND STEWARDSHIP

  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2022 (University)
  • Second prize winner for Poster presentation: Therapeutic effect of Plasma Exchange in steroid refractory inflammatory demyelination of Central nervous system: Outcome from a tertiary centre in Malaysia
    Malaysian Society of Neurosciences, 2018 (National)
  • First prize winner For Poster presentation
    Malaysian Society of Neuroscience, 2012 (National)

PUBLICATIONS

Article in Journal
WoS
  1. Cheok, Y. Y., Tan, G. M. Y., Fernandez, K. C., Chan, Y. T., Lee, C. Y. Q., Cheong, H. C., . . . Wong, W. F. (2021). Podoplanin Drives Motility of Active Macrophage via Regulating Filamin C During Helicobacter pylori Infection. Frontiers in Immunology, 12. doi: 10.3389/fimmu.2021.702156
  2. Cheok, Yi Ying; Lee, Chalystha Yie Qin; Cheong, Heng Choon; Vadivelu, Jamuna; Looi, Chung Yeng; Abdullah, Suhailah; Wong, Won Fen (2021). An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment, MICROORGANISMS. 9(12). doi:10.3390/microorganisms9122502
  3. Lim, J. A., Lee, S. T., Moon, J., Jun, J. S., Kim, T. J., Shin, Y. W., . . . Lee, S. K. (2019). Development of the clinical assessment scale in autoimmune encephalitis. Annals of Neurology, 85(3), 352-358. doi:10.1002/ana.25421
Others
  1. 1.Shanthi Viswanathan, Lavanya Vijayasingham, Joanna Laurson-Doube, Suhailah Abdullah, Su-Yin Lim, et al. Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and recommendations for improvement. Multiple sclerosis and Related Disorders. 2024, 85, 105555
  2. Chalystha Yie Qin Lee , Yee Teng Chan, Suhailah Abdullah et al. Helicobacter pylori Infection Elicits Type I Interferon Response in Human Monocytes via Toll-Like Receptor 8 Signaling. Journal of Immunology Research 2022; Article ID 3861518, 12 pages. https://doi.org/10.1155/2022/3861518.
  3. Cheok, Y.Y.; Tan, G.M.Y.; Lee, C.Y.Q.; Abdullah, S.; Looi, C.Y.; Wong,W.F. Innate Immunity Crosstalk with Helicobacter pylori: Pattern Recognition Receptors and Cellular Responses. Int. J. Mol. Sci. 2022, 23, 7561. https://doi.org/10.3390/ijms23147561
  4. Najafi, P.; Hadizadeh, M.; Cheong, J.P.G.; Mohafez, H.; Abdullah, S. Cytokine Profile in Patients with Multiple Sclerosis Following Exercise: A Systematic Review of Randomized Clinical Trials. Int. J. Environ. Res. Public Health 2022, 19, 8151. https://doi.org/10.3390/ijerph19138151
  5. Yang Feng, Li Sze Chow, Nadia Muhammad Gowdh, Norlisah Ram, Li Kuo Tan, Suhailah Abdullah, Sew Sun Tiang. Gradient-based edge detection with skeletonization (GES) segmentation for magnetic resonance optic nerve images. Biomedical Signal Processing and Control 80 (2022) 104342. https://doi.org/10.1016/j.bspc.2022.104342
  6. Cheok YY, Tan GMY, Fernandez KC, Chan YT, Lee CYQ, Cheong HC, Looi CY, Vadivelu J, Abdullah S and Wong WF (2021) Podoplanin Drives Motility of Active Macrophage via Regulating Filamin C During Helicobacter pylori Infection. Front. Immunol. 12:702156. doi: 10.3389/fimmu.2021.702156
  7. Fauzi, N. A. M., Abdullah, S., Tan, A. H., Ramli, N. M., Tan, C. Y., & Lim, S. Y. (2019). Relapsing encephalopathy with dancing eyes and jerky limbs. Parkinsonism & Related Disorders.
  8. Jung-Ah Lim, Soon-Tae Lee, Jangsup Moon, Jin-Sun Jun, Tae-Joon Kim, Yong-Won Shin, Suhailah Abdullah et al. Development of the Clinical Assessment Scale in Autoimmune Encephalitis. Annals of Neurology 2019; 9999: 1 8. DOI: 10.1002/ana.25421.
  9. Mohd Fauzi NA, Abdullah S, Tan AH, Mohd Ramli N, Tan CY, Lim SY. Relapsing encephalopathy with dancing eyes and jerky limbs. Relapsing encephalopathy with dancing eyes and jerky limbs. Parkinson and Related Disorders 2019. doi.org/10.1016/j.parkreldis.2019.02.025.
  10. Suhailah Abdullah. Neuromyelitis optica spectrum disorder with Miller Fischer Syndrome-like presentation: A case report. J Mult Scler 2019. Ms. No. Biomedical Journals-18-1225R1.
  11. S Abdullah, and CT Tan. Therapeutic effect of Plasma Exchange in steroid refractory inflammatory demyelination of Central nervous system: Outcome from a tertiary centre in Malaysia. Journal of Multiple sclerosis
  12. S Visvanathan, SYH Kar, V Goyal, M Apiwattanakul, UN Thirugnanam, S Abdullah, SMM Aye6, Fu Liong Hiew (2018). Second regional plasmapheresis conference and workshop for Southeast Asia (SEA) on the immunomodulatory role of plasma exchange in central and peripheral nervous system disorders,Kuala Lumpur, Malaysia, 9th December 2017. J Clin Apheresis; 00:1-10. DOI: 10.1002/jca.21630
  13. Mei-Ling Sharon TAI, Hazman MOHD NOR, Kartini RAHMAT, Shanthi VISWANATHAN, Khairul Azmi ABDUL KADIR, Norlisah RAMLI, Fatimah Kamila ABU BAKAR, Norzaini Rose MOHD ZAIN, Suhailah ABDULLAH, Jun Fai YAP, Ahmed SHAHEED, Boon Seng NG, Mohd Hanip RAFIA, Chong Tin TAN.Neuroimaging findings are sensitive and specific in diagnosis of tuberculous meningitis.Neurology Asia 2017; 22(1) : 15 23
  14. S Abdullah, Tan CT. Optic Neuritis. MS Navigator, 2017;2:1-6
  15. S. Abdullah,1 W. F. Wong,2 and C. T. Tan1, 2017. The Prevalence of Anti-Aquaporin 4 Antibody in Patients with Idiopathic Inflammatory Demyelinating Diseases Presented to a Tertiary Hospital in Malaysia: Presentation and Prognosis. Multiple Sclerosis International Volume 2017, Article ID 1359761, 6 pages
  16. Suhailah Abdullah, Farhana Fadzli, Norlisah Ramli, Chong Tin Tan, There is less MRI brain lesions and no characteristic MRI Brain findings in IIDDs patients with positive AQP4 serology among Malaysians, Multiple Sclerosis and Related Disorders, Available online 29 December 2016, ISSN 2211-0348, http://dx.doi.org/10.1016/j.msard.2016.12.011. (http://www.sciencedirect.com/science/article/pii/S2211034816302486)
  17. Shanthi Viswanathan, Suhailah Abdullah, Joyce Joseph et al, 2016. Clinical Practice Guidelines: Management of Multiple Sclerosis. MOH
  18. Sherrini Bazir Ahmad, Suhailah Abdullah, Chong Tin Tan, Kheng Seang Lim, Khean Jin Goh. Spontaneous remission without progression to limbic encephalitis in a patient with LGi1 seropositive faciobrachial dystonic seizure. Neurology Asia 2016; 21(2) : 191 193.
  19. Suhailah Abdullah. Treatment modalities in Multiple Sclerosis and NMOSD: The effect of anti AQP4 antibody. IJAR 2016; 6(8): 38 41.
  20. Cheng Yin Tan, Ganeshwara Lingam, Kartini Rahmat, Suhailah Abdullah, Ai Huey Tan, Mei-Ling Sharon Tai, Norlisah Ramli, Wong Kum Thong, Chong Tin Tan. Primary Angiitis of the Central Nervous System with Myelopathy as Initial Clinical Presentation. Neurology Asia, 2015; 20: 79-84.
  21. Sook Hui Chaw, Li Lian Foo, Lucy Chan, Kang Kwong Wong, Suhailah Abdullah, Boon Kiong Lim. Anesthesia in anti-N-methyl-d-aspartate receptor encephalitisis general anesthesia a requisite? A case report. Rev Bras Anestesiol. 2015;xxx(xx):xxx---xxx. (ISI-Cited Publication)
  22. Suhailah Abdullah, Kheng Seang Lim, Won Fen Wong, Hui Jan Tan, Chong Tin Tan. EEG is sensitive in early diagnosis of anti NMDAR encephalitis and useful in monitoring disease progress.Neurology Asia 2015; 20(2) : 167-175
  23. Khean-Jin Goh, Suhailah Abdullah, Won Fen Wong, Swan-Sim Yeap, Nortina Shahrizaila, Chong-Tin Tan. Cold allodynia as the presenting symptom in a case of acquired neuromyotonia (Isaacs syndrome) with multiple autoantibodies. Neurology Asia 2014; 19(4) : 409 412.
  24. Nortina Shahrizaila, Khean Jin Goh , Suhailah Abdullah , Rishikesan Kuppusamy , Nobuhiro Yuki. Two sets of nerve conduction studies may suffice in reaching a reliable electrodiagnosis in Guillain Barr syndrome. Clinical Neurophysiology 124 (2013) 1456 1459
  25. Abdullah S, Chang LY, Rahmat K, Goh KJ, Tan CT. 2002. Late-onset Nipah virus encephalitis 11 years after the initial outbreak: A case report. Neurology Asia 17 (1):71-4.
  26. Abdullah S, Lim SY, Goh KJ, Lum LCS, Tan CT. Anti-N- methyl-D-aspartate receptor (NMDAR) encephalitis: A series of ten cases from a university hospital in Malaysia. Neurology Asia 2011;16(3):241-246.
  27. Shahrizaila N, Goh KJ, Kokubun N, Abdullah S, Yuki N. Serial nerve conduction studies provide insight into the pathophysiology of Guillain- Barre and Fisher syndromes. Journal of the Neurological Sciences 2011;309(1-2):26-30
  28. Kartini Rahmat, Shaleen Kaur, Norlisah Mohd Ramli, Patricia Ann Chandran, Kum-Thong Wong, Suhailah Abdullah, Sharifah S Omar, Dharmendra Ganesan, Chong-Tin Tan. Progressive multifocal leukoencephalopathy limited to the posterior fossa. Neurology Asia 2010; 15(3) : 283 286
  29. Chong HT, Abdullah S, Tan CT. Nipah virus and bats. Neurology Asia 2009;14:73-6.
Chapter in Books
  1. 1.Yi Ying Cheok, Suhailah Abdullah, and Won Feng Wong. Chapter 19 - Transcriptional regulatory network associated with multiple sclerosis pathogenesis. Transcription and translation in Health and Disease, 2023: 359-365.
  2. Suhailah Abdullah, Tan Chong Tin. Chapter 32 Henipavirus encephalitis. Handbook of Clinical Neurology, 2014: 123; 663 670.
Article in Proceeding
  1. Yang Feng, Li Sze Chow, Sew Sun Tiang, Norlisah Ramli, Nadia Muhammad Gowdh, Li Kuo Tan, Suhailah Abdullah. Bicubic Interpolation and Gradient-Based Edge Detection With Skeletonization Segmentation (Bicubic-GES) on MR Optic Nerve Images for Examining NMOSD. IEEE-EMBS Conference on Biomedical Engineering and Sciences (IECBES), 2022. 1570834396
  2. S Abdullah, WF Wong, Tan Chong Tin, 2016. The prevalence of anti Aquaporin 4 antibody in patients with Idiopathic Inflammatory Demyelinating Diseases presented to University Malaya Medical Centre, Kuala Lumpur, Malaysia: Presentation and prognosis. AOCN;15:
  3. Suhailah Abdullah, Farhana Fadzli, Norlisah Ramli, Chong Tin Tan, 2016. There is less MRI brain lesions and no characteristic MRI Brain findings in IIDDs patients with positive AQP4 serology among Malaysians. ECTRIMS;32:
  4. Suhailah Abdullah, Lim Kheng Seang, Tan Hui Jan, Wong Won Fen, Tan Chong Tin. EEG is Sensitive in Early Diagnosis of Anti NMDAR Encephalitis and Useful in Monitoring Disease Progress.Lancet Neuroimmunology Conference, 2015.
  5. Thrombolysis and Endovascular Therapy in a tertiary hospital in Malaysia. Tai MLS, Azmi K,Janjua NS, Kuppusamy R, Abdullah S, Goh KJ, Zakaria MI, Hazman MN, Tan CY, Tan AH, Ibrahim KA, Chong GM, Tan CT, Tan KS. Cerebrovascular Dis 2013;36(suppl 1):1-94
  6. S Abdullah, S S.Tamim, I Zainal Abidin, W Azman. THE RELATIONSHIP BETWEEN PULMONARY VESSEL CAPACITANCE AND THE SEVERITY OF MITRAL STENOSIS.13th NHAM Scientific Meeting, 2009
Other Publications
  1. Abdullah S (2021. Cerebral Salt Wasting due to Bilateral Hypothamic Lesions as a Presentation of NMOSD: A Case Illustration and Retrospective Review of Local Occurrence. J Neurol Neurosci Vol.12 No.9:391. - Technical Report

RESEARCH INTEREST

  • The prevalence of AQP4 positivity in MS spectrum disease (AQP4, MS/ NMOSD)
  • MRI changes in IIDD with relation to the AQP4 status (MRI, AQP4)
  • Response to Plasma exchange in the treatment of steroid failure acute relapse: Is there a difference in relation to AQP4 status? (Plasma exchange, acute relapse, AQP4)

RESEARCH PROJECT

National
  1. 2019 - 2023, Fundamental Research Grant Scheme (FRGS)
    Immunological Association Of Podoplanin In Multiple Sclerosis (ms) And Neuromyelitis Optica Spectrum Disorder (nmosd) ( Principal Investigator(PI))
  2. 2020 - 2023, RU Geran - Fakulti Program
    The Effects Of Genetic Singlenucleotide Polymorphism (snp) And Stress Level On Predicting Onset Among Multiple Sclerosis (ms) And Neuromyelitis Optica Spectrum Disorder (nmosd) Patients ( Co-Researcher)
  3. 2020 - 2023, RU Geran - Fakulti Program
    The Balance Of Regulatory T And T Helper 17 (th17) Cells In Neuroinflammation Of Multiple Sclerosis (ms) And Neuromyelitis Optica Spectrum Disorder (nmosd) Patients ( Co-Researcher)
  4. 2020 - 2023, RU Geran - Fakulti Program
    The Effect Of Rituximab On B Cell Depletion In Patients With Neuromyelitis Optica Spectrum Disorder (nmosd) And Multiple Sclerosis (ms): Treatment Resistant Versus Treatment Failure ( Principal Investigator(PI))
  5. 2013 - 2015, Others MOHE
    Geran Sanjungan Penyelidikan Mo031-2013 ( Principal Investigator(PI))
  6. 2021 - 2025, Merck Healthcare KgaA
    A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Teriflunomide, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety ( Principal Investigator(PI))
  7. 2019 - 2022, NOVARTIS CORPORATION (M) SDN. BHD.
    A 12 WEEK PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE MONTHLY SUBCUTANEOUS ERENUMAB 70MG IN ADULT CHRONIC MIGRAINE PATIENTS ( Co-Researcher)
  8. 2019 - 2022, Fundamental Research Grant Scheme (FRGS)
    Immunological and Genetic association of Podoplanin in multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) ( Principal Investigator(PI))
  9. 2012 - 2017, Novartis Corporation (M) Sdn. Bhd.
    A Single Arm, Open-Label, Multicenter Study Evaluating the Long Term Safety, Tolerability and Efficacy of 0.5mg Fingolimod (FTY720) Administered Orally Once Daily in Patients with Multiple Sclerosis. ( Principal Investigator(PI))
  10. 2011 - 2016, High Impact Research (HIR)
    Autoimmune encephalitis and the possibility of discovering a new antigen ( Principal Investigator(PI))
  11. 2013 - 2015, Ministry of Education
    Development of CPG for Multiple Sclerosis ( -Developing commitee)
  12. 2012 - 2014, Novartis Corporation (M) Sdn. Bhd.
    A 4-Month, Open-Label, Multi-Center Study to Explore the Safety and Tolerability of Fingolimod 0.5mg in Patients with Relapsing-Remitting Multiple Sclerosis. ( Principal Investigator(PI))
  13. 2008 - 2011, Janssen-Cilag
    Double blind, placebo controlled, multi centre acute study of effectiveness of Nesiritides in subject with decompensated Heart Failure ( Consultant)
Private
  1. 2022 - 2024, Research Excellence & Innovation Grant (REIG)-FETBE-2022/024
    Study of Neuromyelitis optica spectrum disorder (NMOSD) effect on optic nerve volume using Magnetic Resonance Imaging (MRI), UCSI University ( Co-Researcher)
  2. 2018 - 2021, Novartis Corporation (M) Sdn. Bhd.
    A 12-week double-blind, randomized, multi-center study comparing the efficacy and safety of once monthly subcutaneous AMG 334 against placebo in adult episodic migraine patients (EMPOwER) ( Co-Researcher)
International
  1. 2022 - 2025, International Funding
    Gpp - Accelerating The Diagnosis Of Neuroinfection In Malaysia ( Co-Researcher)
  2. 2020 - 2023, Private Funding
    A phase III, multi-center, randomized, parallel group, double-blind, double-dummy, active controlled study of Evobrutinib compared with Teriflunamide, in participants with Relapsing Multiple Sclerosis to evaluate efficacy and safety. ( Principal Investigator(PI))
  3. 2018 - 2020, Private Funding
    EMPOWER AMG334A2302 ( Sub-Investigator)
  4. 2019 - 2020, Private Funding
    DRAGON A 12-week phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of once monthly subcutaneous erenumab 70 mg in adult chronic migraine patients. ( Consultant)
  5. 2018 - 2018, Private Funding
    Development of theClinical Assessment Scale in Autoimmune Encephalitis (CASE) ( Consultant)
  6. 2012 - 2017, NOVARTIS
    The long term safety of Fingolimod in the treatment of Multiple sclerosis ( Principal Investigator(PI))
  7. 2012 - 2014, NOVARTIS
    The Efficacy and safety of Fingolimod in the treatment of Multiple Sclerosis (short term) ( Principal Investigator(PI))
  8. 2008 - 2011, Janssen-Cilag
    Double-blind, placebo-controlled, multicenter acute study of clinical effectiveness of Nesiritide in subjects with decompensated heart failure. ( Co-Researcher)

CONSULTANCY PROJECT

  • Management of Ms - Focus On Covid-19 Vaccination Advisory Board Meeting, MERCK, Consultant
    24 Mar 2022 - 24 Mar 2022 (International)
  • Hong Kong Advisory Board Meeting On Treatment Updates in Ms, Merck
    01 Dec 2018 - 01 Dec 2018 (International)
  • Ms Scientific Advisory Board Meeting, NOVARTIS
    01 Feb 2014 - 01 Feb 2014 (International)
  • Experience Sharing in Ms, Novartis
    01 Feb 2013 - 01 Feb 2013 (International)
  • Sativex Use in Spasticity in Ms, Norvatis
    01 Feb 2013 - 01 Feb 2013 (International)

PAPER PRESENTED

INVITED SEMINAR
  1. Discussion panel, A New step in MS, Prague (International) (09 Jun 2011 - 11 Jun 2011)
INVITED SPEAKER
  1. Autoimmune Diseases of the CNS, UMMPY2 Neurology Block, MERDU (University) (26 Nov 2019 - 26 Nov 2019)
  2. Autoimmune encephalitis, 21st Asia-Pacific Regional Conference of Alzheimer's Disease International, Alzheimer's Disease International (International) (16 Aug 2019 - 18 Aug 2019)
  3. Anti NMDAR Encephalitis, Royal College of Physicians Updates in Internal Medicine, Royal Collage of Physicians (National) (21 Jun 2019 - 23 Jun 2019)
  4. Autoimmune encephalitis, Neurology Lecture series, Neurology Unit (University) (14 Dec 2018 - 14 Dec 2018)
  5. Autoimmune diseases of the CNS: MS vs NMOSD, UMMP 2.0 Neurology Block, MERDU (University) (06 Dec 2018 - 06 Dec 2018)
  6. Autoimmune diseases of the CNS: MS vs NMOSD, Neurology lecture series, Neurology Unit (University) (09 Nov 2018 - 09 Nov 2018)
  7. Autoimmune encephalitis: NMDAR and other auto-immune encephalitis, KPJ Healthcare Conference, KPJ Health group (National) (19 Oct 2018 - 21 Oct 2018)
  8. Update on anti NMDAR encephalitis, 17th AOMC & 28th MSN Annual Scientific Meeting 2018 (AOMC-MSN 2018), AOMC-MSN (International) (27 Jul 2018 - 29 Jul 2018)
  9. Autoimmunity and seizure: Updates on anti NMDAR and LGI-1 encephalitis, 12th Asian Oceanic Epilepcy Congress (AOEC), Asian Oceanic Epilepcy Congress (AOEC) (International) (28 Jun 2018 - 01 Jul 2018)
  10. NMDARE and Psychiatry, NEUROPSYCHIATRY CONFERENCE (2018-2019), Psychiatry and Neurology Department (University) (25 Apr 2018 - 25 Apr 2018)
  11. CNS infection, UMMP 3.1 Lecture series, MERDU (University) (20 Feb 2018 - 20 Feb 2018)
  12. Autoimmune Encephalitis: management and the role of plasmapheresis, The 2nd Annual Malaysian Conference & Workshop on the Immunomodulatory role of Plasmapheresis in Peripheral& Central Nervous System Disorders: A Practical approach and New knowledge, KKM and MSN (International) (09 Dec 2017 - 09 Dec 2017)
  13. Autoimmune diseases of the CNS: MS/ NMOSD/ ADEM, Neurology Block Lecture UMMP 2.0, MERDU (University) (28 Nov 2017 - 28 Nov 2017)
  14. Updates in the Concept and Treatment of MS, Update in Multiple Sclerosis, Queen Elizabeth Hospital in association with Novartis (National) (10 Nov 2017 - 10 Nov 2017)
  15. MS vs NMOSD, Updates on Multiple Sclerosis, Queen Elizabeth Hospital with association of Novartis (National) (10 Nov 2017 - 10 Nov 2017)
  16. Auto-immune Encephalitis, Neurology series of Lecture for Post Graduates, Unit Neurology (University) (13 Oct 2017 - 13 Oct 2017)
  17. Present and Future Multiple Sclerosis: What Do We Know Now?, 360 degree Neuro Science Meeting 2017, MSN with association with Novartis  (National) (30 Sep 2017 - 30 Sep 2017)
  18. Demyelinating Diseases of the CNS, Neurology Lecture series for Post Graduates, Neurology Unit (University) (14 Jul 2017 - 14 Sep 2017)
  19. CNS infection, CNS lecture series UMMP 3.1, MERDU (University) (17 Jan 2017 - 17 Jan 2017)
  20. Auto-immune diseases of the CNS: MS and NMOSD, Neuro Block 7 lecture series UMMPY2, MERDU (University) (22 Nov 2016 - 22 Nov 2016)
  21. Anti NMDAR encephalitis, Neuroimmunology and Neuroinfection Workshop, MSN Neuroimmunology Council and UCB/ Merck (National) (03 Sep 2016 - 03 Sep 2016)
  22. Epidemiolology and Clinical Features of MS, Train the Trainer Workshop (MS CPG), Ministry of Health (National) (02 Aug 2016 - 02 Aug 2016)
  23. Case Discussion 1: Epidemiology & Clinical Features, Teach the trainer MS CPG workshop, MOH (National) (02 Aug 2016 - 02 Aug 2016)
  24. Treatment failure in MS, EAST COAST MULTIPLE SCLEROSIS UPDATE 2016, Neurology Unit and Kelab Medik Hospital Sultanah Nur Zahirah (National) (31 Jul 2016 - 31 Jul 2016)
  25. MS vs NMOSD, MS Eastcoast Workshop, Neurology Unit and Kelab Medik Hospital Sultanah NurZahirah (National) (31 Jul 2016 - 31 Jul 2016)
  26. Autoimmune Encephalitis, Immune System and Nerves: An Introductory Lecture Series, MSN Neuroimmunology Council and Axisbio (National) (28 Jul 2016 - 28 Jul 2016)
  27. Structure and function of Peripheral Nerves, Neurology block UMMPY2 (University) (27 Nov 2015 - 27 Nov 2015)
  28. Autoimmune diseases of the CNS: MUltiple Sclerosis, Neurology Block UMMPY2 (University) (26 Nov 2015 - 26 Nov 2015)
  29. Autoimmune encephalitis, Neurology Lecture Series 2015 (University) (04 Nov 2015 - 04 Nov 2015)
  30. Autoimmune diseases of the CNS: Multiple Sclerosis, Neurology Lecture series 2015 (University) (07 Oct 2015 - 07 Oct 2015)
  31. Inflammatory Demyelinating Diseases of The CNS: Multiple Sclerosis, Medical Department CME (University) (29 Sep 2015 - 29 Sep 2015)
  32. Headache and gait, MBBS phase 3A, Klang posting (University) (05 Aug 2015 - 05 Aug 2015)
  33. Multiple Sclerosis, MBBS phase 3A, Klang posting (University) (29 Jul 2015 - 29 Jul 2015)
  34. Autoimmune disorders of the nervous system, Neurosciences, Vision & Behaviour- Block 7  (University) (22 Jan 2015 - 22 Jan 2015)
  35. Autoimmune Encephalitis, Inter-Departmental Symposium (University) (21 Jan 2015 - 21 Jan 2015)
  36. Health Assessment: Nervous system, Degree of Nursing (University) (17 Nov 2014 - 17 Nov 2014)
  37. Multiple Sclerosis, Opthalmology Department CME (University) (29 Oct 2014 - 29 Oct 2014)
  38. Health Assessment: Nervous system, Degree of Nursing (University) (22 Oct 2013 - 22 Oct 2013)
  39. Autoimmune encephalitis, ASNA, Brunei (International) (18 Oct 2013 - 20 Oct 2013)
  40. Autoimmune encephalitis, MSN, Kuching (National) (14 Jun 2013 - 16 Jun 2013)
  41. Diabetic Neuropathy , Diploma Lanjutan Kejururawatan (University) (20 Mar 2013 - 20 Mar 2013)
  42. Health Assessment of Human Function III :* Nervous System , Degree of Nursing, Department of Nursing (University) (29 Nov 2011 - 29 Nov 2011)
  43. Anti-NMDAR Encephalitis, ASNA, Bali (International) (02 Nov 2011 - 05 Nov 2011)
  44. Cerebral Vascular Emergencies : Acute brain attacks, Status epilepticus, Electroencephalography, Etiology, pathophysiology and management , Diploma Lanjutan Kejururawatan, Department of Nursing (University) (05 Oct 2011 - 05 Oct 2011)
  45. Diabetic Neuropathy , Diploma Lanjutan Kejururawatan, Department of Nursing (University) (14 Mar 2011 - 14 Mar 2011)
  46. Health Assessment of Central Nervous System Function , Degree of Nursing (University) (21 Sep 2010 - 21 Sep 2010)
  47. Introduction to Neurology, Bio-Engineering, Biomedical engineering Department (University) (14 Jul 2010 - 14 Jul 2010)
EVENT ORGANISER
  1. Organizer, Neuroimmunology and Neuroinfection Workshop, MSN Neuroimmunology Council and UCB/ Merck (National) (03 Sep 2016 - 03 Sep 2016)
  2. Organizer, Immune System and Nerves: An Introductory Lecture Series, MSN Neuroimmunology Council and Axisbio (National) (28 Jul 2016 - 28 Jul 2016)
ORAL PRESENTER
  1. The prevalence of anti Aquaporin 4 antibody in patients with Idiopathic Inflammatory Demyelinating Diseases presented to University Malaya Medical Centre, Kuala Lumpur, Malaysia: Presentation and prognosis, Asian Oceanic Conference of Neurology, MSN (International) (18 Aug 2016 - 21 Aug 2016)
  2. Acute Intermittent Porphyria, MSN, Kuala Terengganu (National) (27 May 2011 - 29 May 2011)
  3. Fits, Psychiatric symptoms and Abnormal movement - What could it be?, MSN (National) (21 May 2010 - 23 May 2010)
POSTER PRESENTER
  1. Cerebral salt wasting due to bilateral hypothalamic lesions as a presentation of NMOSD: A case illustration and retrospective review of local occurrence., Pan Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), PACTRIMS (International) (26 Nov 2021 - 28 Nov 2021)
  2. Bilateral facial palsy, opthalmoplegia and ataxia: A case of Neuromyelitis optica spectrum disorder mimicking the presentation of Miller Fisher Syndrome, Demyelinating diseases of the CNS: Current concept and treatment updates, Malaysian Society of Neurosciences in association with Merck and Novartis (National) (17 Nov 2018 - 17 Nov 2018)
  3. Therapeutic effect of Plasma Exchange in steroid refractory inflammatory demyelination of Central nervous system: Outcome from a tertiary centre in Malaysia, Demyelinating diseases of the CNS: Current concept and treatment updates, Malaysian Society of Neurosciences in association with Merck and Novartis (National) (17 Nov 2018 - 17 Nov 2018)
  4. There is less MRI brain lesions and no characteristic MRI Brain findings in IIDDs patients with positive AQP4 serology among Malaysians., European Committee for the Treatment of Multiple Sclerosis, ECTRIMS (International) (14 Sep 2016 - 17 Sep 2016)
  5. Treatment modalities in Multiple Sclerosis and NMOSD: The effect of anti AQP4 antibody., Asian Oceanic Conference of Neurology, MSN (International) (18 Aug 2016 - 21 Aug 2016)
  6. EEG is Sensitive in Early Diagnosis of Anti NMDAR Encephalitis and Useful in Monitoring Disease Progress, Lancet Neurology Autoimmune Disorder Conference, Barcelona (International) (25 Mar 2015 - 27 Mar 2015)
  7. EEG is Sensitive in Early Diagnosis of Anti NMDAR Encephalitis and Useful in Monitoring Disease Progress. , MSN, Putrajaya (National) (06 Jul 2012 - 08 Jul 2012)
  8. Tip of the Basilar artery syndrome with good resolution to medical treatment: A Case Report., MSN, Putrajaya (National) (06 Jul 2012 - 08 Jul 2012)
  9. Biochemistry and Microscopic finding in CSF of Normal Population., MSN (National) (21 May 2010 - 23 May 2010)
OTHERS
  1. Neuro Immunology Session, 360 degree Neuroscience Meeting 2017, MSN in association with Novartis (National) (30 Sep 2017 - 30 Sep 2017)
  2. Facilitator, Train the trainer workshop (MS CPG), Ministry of Health (National) (02 Aug 2016 - 02 Aug 2016)
  3. Update in the treatment of MS and NMOSD, PACTRIMS 2015 (International) (19 Nov 2015 - 21 Nov 2015)
  4. The chnaging paradigm of MS Management: BG12, MS symposium (National) (07 Sep 2015 - 07 Sep 2015)
  5. Participant, EXCEMED Annual conference in MS, Dubai (International) (09 May 2014 - 10 May 2014)
  6. Participant, PACTRIMS, Kyoto (International) (06 Nov 2013 - 08 Nov 2013)
  7. Participant, ECTRIMS, Lyon (International) (10 Oct 2012 - 13 Oct 2012)
  8. Participant, PACTRIMS, Beijing (International) (13 Sep 2012 - 15 Sep 2012)
  9. Participant, Asian Regional Medical Conference, Hong Kong (International) (05 May 2012 - 06 May 2012)
  10. Participant, Dementia Workshop (National) (25 Apr 2010 - 27 Apr 2010)
  11. Participant, World Congress of Neurology (International) (26 Oct 2009 - 31 Oct 2009)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2022) Dom Research Support Fund, University, (Internal Evaluator)
  2. (2022) A Comparison of The Effect of Relaxation Exercises On The Immune System and Hormones With Quality of Life and Fatigue Levels in Multiple Sclerosis Patients, International, (External Evaluator)
  3. (2022) Umsc C.a.R.E Research Grant, University, (Internal Evaluator)
  4. (2022) Co-Occurrence of Anti-Nmdar Encephalitis and Covid-19 Infection Case Series of Two Patients With a Brief Review of Literature: Co-Occurrence of Anti-Nmdar Encephalitis and Covid-19 Infection, International, (External Evaluator)
  5. (2022) Frgs Evaluator, University, (Reviewer)
  6. (2021) Master of Medicine Part 1 Examination, National, (External Examiner)
  7. (2021) Dom Rse Fund Grant, University, (Reviewer)
  8. (2021) Osce Ummp 2.0, University, (Internal Examiner)
  9. (2021) "High-Dose Oral Versus Intramuscular Vitamin D3 Supplementation in Multiple Sclerosis Patients: a Randomized Clinical Trial: Oral Vs. Intramuscular Vitamin D Supplementation in Ms: a Rct", International, (Reviewer)
  10. (2021) Master of Medicine Part 2 Conjoint Examination, National, (Internal Examiner)
  11. (2021) Umsc Ca.R.E Fund Research Grant 2021 Application, University, (Reviewer)
  12. (2021) Master of Medicine Mock Thesis Examination, University, (Internal Examiner)
  13. (2021) Master of Science Candidature Defense, University, (Internal Examiner)
  14. (2020) Mygrant Frgs Evaluation Panel, National, (Reviewer)
Contribution to event
  1. (2022) Autoimmune Encephalitis: Experience Sharing from The University Hospital- Invited Speaker, National, (Panelist/Moderator)
  2. (2022) Autoimmune Encephalitis: Complexity of Presentation - Invited Speaker, International, (Panelist/Moderator)
  3. (2022) Management of Ms - Focus On Covid-19 Vaccination Advisory Board Meeting: Panelist, International, (Panelist/Moderator)
  4. (2021) Autoimmune Encephalitis: The Rewards and Challenges, National, (Panelist/Moderator)
  5. (2021) Autoimmune Diseases of The Cns, University, (Panelist/Moderator)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2023) Investigating the Functions of Helper T and Circulating Helper-like Innate Lymphoid Cells in Mediating the Disease Onset and Relapses of Autoimmune Demyelinating Disease of the Central Nervous System, LOH KAR MIN
  2. (2023) The Effects of Tele-Yoga and Tele-Pilates on Selected Hormonal, Physical and Psychological Outcomes in Patients with Multiple Sclerosis, PARISA NAJAFI
  3. (2019) Immunological and genetical associations of Podoplanin in multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), Cheok Yi Ying
Master
  1. (2021) -, GIRISHRAJ RAJANDRAN
  2. (2020) -, MOHAMAD FIRDAUS BARAKATH
  3. (2020) -, MUHAMAD SUFIAN BIN SULAIMAN
  4. (2019) Comparison of radiomic biomarkers and magnetic resonance imaging characteristics in differentiating neuromyelitis optica spectrum disorder and multiple sclerosis, Viknesh Balasingam
  5. (2018) COMPARISON OF BIOCHEMICAL PARAMETERS AND MAGNETIC RESONANCE IMAGING CHARACTERISTICS IN DIFFERENTIATING INFECTIOUS ENCHEPHALITIS (IE) AND AUTOIMMUNE ENCHEPHALITIS (AE), VINOSHINI NAIR SUKUMARAN
  6. (2018) COMPARISON OF RADIOMIC BIOMARKERS AND MAGNETIC RESONANCE IMAGING CHARACTERISTICS IN DIFFERENTIATING NEUROMYELITIS OPTICA SPECTRUM DISORDER AND MULTIPLE SCLEROSIS, VIKNESH BALASINGAM
  7. (2016) Completed, Kumara Guru
  8. (2016) -, KUMARA GURU A/L SUBRAMANIAM
  9. (2015) Anti-NMDAR Encephalitis, Alan Basil Peter
  10. (2014) Completed, Noor Hazirah Binti Rezali
  11. (2014) -, NOOR HAZIRAH BINTI REZALI
  12. (2011) -, ANG CHENG LUNG
  13. (2010) Stroke Amongst South East Asian Patients: Relationship To Atrial Fibrillation Morbidity And Mortality At University Malaya Medical Centre, Dr Emma Binti Yaakop
  14. (2010) Short term outcome of ESRF: Patients who are newly started on dialysis, Dr Ang Cheng Lung
  15. (2010) -, EMMA BINTI YAAKOP
Under Graduate Students
  1. (2019) Mentor-Mentee Programme
  2. (2014) MBBS
  3. (2013) MBBS

SOCIAL RESPONSIBILITY ACTIVITIES

  • Neuroimmunology in Normal and Challenging Times: 23rd to 25th August 2020, Melaka (Kkm): Invited Speaker, (23 Aug 2020 - 25 Aug 2020) (National)
  • Organizing Committee for 2nd Updates in Cns Infection, (30 Nov 2019 - 30 Nov 2019) (National)
  • Scientific and Organizing Committee for 2nd Demyelinating Diseases of The Cns: Current Concept and Treatment Updates, (19 Oct 2019 - 19 Oct 2019) (National)
  • Invited Speaker for 21st Asia-Pacific Conference of Alzhiemer’S Disease International, (16 Aug 2019 - 18 Aug 2019) (International)
  • Invited Speaker for College of Physicians Regional Conference 2019: Updates in Internal Medicines, (21 Jun 2019 - 23 Jun 2019) (National)
  • Speaker for Kpj Health Forum, (20 Oct 2018 - 20 Oct 2018)
  • Speaker for Aomc On Aie, (27 Jul 2018 - 29 Jul 2018)
  • Protocol for Iv Rituximab, Mitoxantrone and Cyclophosphamide Use in Neurology, (01 Jan 2018 - 31 Dec 2018)
  • Organizing Committee for Demyelinating Diseases of The Cns: Current Concept and Treatment Updates., (01 Jan 2018 - 18 Nov 2018)
  • Scientic Committee for 3rd Regional Annual Sea Tpe Conference, (01 Jan 2018 - 15 Dec 2018)
  • Organizing Committee for Updates On Cns Infection, (01 Jan 2018 - 12 Aug 2018)
  • Patient Information Sheet for Azathioprine, Mycophenalate Mofetil, Rituximab, Cyclophosphamide and Mitoxantrone, (01 Jan 2018 - 31 Dec 2018)
  • Multiple Sclerosis Update Course Queen Elizabeth Hospital, Sabah, (10 Nov 2017 - 10 Nov 2017)
  • Scientific Committee for 2nd Annual Plasmapheresis Course, (12 Oct 2017 - 09 Dec 2017)
  • Chairperson and Speaker for 360 Degree Neuroscience Meeting 2017, (30 Sep 2017 - 30 Sep 2017)
  • Committee for National Syllabus for Neurology (Neuro Infection and Immunology Chapter) for Master of Internal Medicine, (17 Aug 2017 - 30 Jun 2018)
  • Ms Awareness Newsletter, (01 Jan 2017 - 28 Feb 2017)
  • Facilitator for Train The Trainer Workshop for The National Implementation of Ms Cpg, (02 Aug 2016 - 02 Aug 2016)
  • Clinical Practice Guideline for Multiple Sclerosis, (01 Jan 2013 - 19 Aug 2016)
  • Multiple Sclerosis Awareness Campaign, 2012, (02 Apr 2012 - 30 Sep 2012)

COURSE ATTENDED

Internal / External Course
CONFERENCE
  1. VIRTUAL CONFERENCE EUROPEAN CONGRESS FOR THE TREATMENT OF MULTIPLE SCLEROSIS 2021, Virtual from Vienna (13 Oct 2021 - 15 Oct 2021)
  2. ASIA-PACIFIC NEUROPSYCHIATRIC CONFERENCE 2022 (NEURON 2022), Hotel Pullman, Kl (17 Jun 2022 - 17 Jun 2022)